Thromboprophylaxis in patients undergoing endovenous varicose vein treatment
Eligibility
Local study conflicts
Patients can be co-enrolled to other clinical trials as administration of thromboprophylaxis is short term and mirrors standard of care treatments.
Inclusion Criteria:
Adults (>18 years)
Scheduled to undergo to undergo endovenous intervention of truncal varicose veins under local anaesthesia
Treatment technologies including radiofrequency, laser, mechanochemical, foam sclerotherapy and cyanoacrylate glue
Exclusion Criteria:
Clinical indication for therapeutic anticoagulation e.g., atrial fibrillation
Previous personal or first-degree relative history of VTE
Thrombophilia
Female patients of childbearing potential who have a positive pregnancy test
A history of allergy to heparins or direct oral anticoagulants
A history of heparin-induced thrombocytopenia
Inherited and acquired bleeding disorders
Evidence of active bleeding
Concomitant major health problems such as active cancer and chronic renal and/or liver impairment
Known thrombocytopenia (platelets less than 50 x 109/l)
Major trauma or non-venous surgery that required local risk assessment for VTE in the previous 90 days
Recent ischemic stroke in the previous 90 days
If the patient is eligible:
Inform the patient that they may be eligible for a research study
Gain verbal agreement in principle before proceeding. Explain:
Taking part in research is likely to improve the quality of their care
Risks are carefully controlled - research is safe
Explain the uncertainty that exists with respect to treatment of their condition
If they change their mind they can withdraw their participation at any point
Step-by-Step Guide to Recruitment:
In standard working hours
The research nurse team is available from 08am-16pm Monday to Friday;
In research team working hours contact the team via:
Secure Chat: Research Delivery Team EVOCC
Email: cuh.rdt@nhs.net
Time taken to recruit
Thirty minutes
Eligibility confirmation
Eligibility can only be confirmed by clinicians on the delegation log.
Mr Manjit Gohel, consultant vascular surgeon, is the PI and will know which members of staff who are delegated this role.
When the ED Research team is not available:
Patients can not be recruited out of normal working hours
Steps to recruit
Clinical team to have initial conversation with the patient and ask if details can be passed onto the research nurse team . This could be at an out patient appointment or at time of admission for procedure.
Clinic admin staff are also including a short information leaflet with the procedure appointment letter including the research nurse teams contact details so that interested patients can contact the nurse team ahead of their appointment
Research nurse team to send out PIS and follow up to see if they are interested.
Delegated medical team member to document eligibility on EPIC using smartphrase .THRIVEELIGIBILITY
Delegated Research nurses will receive consent and complete all baseline questionnaires
Randomisation procedure
Research Nurse team will complete randomisation and inform clinical teams so allocated prophylaxis can be prescribed.
Carrying out the intervention:
Participants will be individually randomised (stratified by site) to one of three thromboprophylaxis strategies prior to undergoing endovenous treatment:
Compression* alone
Compression* + single dose of low-molecular weight heparin (LMWH) at time of procedure
Compression* + single dose of LMWH at time of procedure + extended prophylactic dose of anticoagulation with LMWH or Direct-Acting Oral Anticoagulants (DOAC)**
*compression bandaging, compression stockings or compression wraps aligning with standard of care
**7, 10 or 14-day course of prophylactic dose LMWH or DOAC as per local preference
Local routine prescribing procedures will be followed for each IMP, for example, the IMP will be prescribed by the participant’s treating clinician according to the trial arm allocation and dispensed by the hospital pharmacy.
Disposition and follow-up:
Follow up is as per standard of care.
In addition a duplex ultrasound appointment will be made between 21 - 28 days post procedureto test for DVT. If positive, the scanning team will contact the on call vascular consultant for advice.
The central team will also follow up remotely at 7 days and 90 days post procedure